Fundación Respirar ( Site 0610)

Buenos Aires, Buenos Aires F.D. C1426ABP

0 studies enrolling now · 2 studies all time

What they study most

Arteriosclerosis, Familial Hypercholesterolemia, Hypercholesterolaemia, Hypercholesterolemia

Studies at this site

• A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids — Completed
• Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes — Running, not enrolling